-
Most Popular
CERN
Billionaire Paul Tudor Jones Is Betting Big on These 3 Stocks
Paul Tudor Jones II first gained notoriety by shorting the Black Monday Crash of 1987. Now, he's betting big on CERN, PLAN, and SPY puts.
ORCL, CERN: 11 Things to Know as Oracle Buys Cerner in $28.3B Mega Healthcare Move
Oracle (ORCL) and Cerner (CERN) stock are in the news Monday thanks to a massive acquisition deal between the two companies.
CERN Stock Alert: Cerner Pops 15% on Acquisition Speculation
CERN stock is popping on rumors that the company could be acquired by Oracle for $30 billion in a blockbuster deal.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!
Cerner Stock Could See a Bump If It Gets Gobbled up By a Cloud Company
Mainstream cloud vendors backed away from the healthcare space a decade ago, fearful of regulation, but they're now adapting to regulation in their main markets and might want to get back in.
Cerner Is a Strong Value Based on Ultra-Firm Financials
Growth investors and dividend collectors alike should consider CERN stock now as the company posts indisputably solid fiscal figures.
Cerner Might Be an Acquisition Target Soon
As rumors swirl around a possible acquisition for electronic health record company Cerner, consider picking up CERN stock.
7 High-Risk Stocks Banking on a Return to Normal
These seven risky stocks might take a breather as the bull market enters a more speculative stage in the new quarter. Proceed with caution.
Stock Market Today: Tesla’s Truck; Uber Out of London?
Tesla unveiled its new pickup, the Cybertruck, to mixed reactions. Here's what happened in the stock market today.
Cerner Layoffs 2019: 16 Things to Know About the CERN Job Cuts
Cerner layoffs are on the way as the company looks to reduce its workforce and increasing its operating margin for Q4 2019.
The Failure of America’s Health-IT System and Amazon’s Opportunity
The real scandal isn't the failure of the stimulus but the response, which was to ditch open-source health-IT solutions that worked for proprietary ones that don't.